Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 15,000
+230 (1.56%)
At close: Sep 9, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 180.29 billion as of September 8, 2025. Its market cap has increased by 13.29% in one year.
Market Cap
180.29B
Enterprise Value
213.80B
Revenue
8.66B
Ranking
n/a
PE Ratio
41.46
Stock Price
15,000.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 180.29B, a decrease of -50.00%. That is a compound annual growth rate of -14.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 177.52B | -2.25% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 37.45T |
| ALTEOGEN | 25.54T |
| Yuhan | 9,104.15B |
| SK Biopharmaceuticals | 8,575.30B |
| PharmaResearch | 7,013.01B |
| Peptron | 6,756.23B |
| LigaChem Biosciences | 5,523.68B |